Article Text

Download PDFPDF
1143 Optimising outcomes in high grade endometrial cancer
  1. Shreya Sanjay Mogre and
  2. Devyani Mahajan
  1. Nanavati Max Institute of Cancer Care, Mumbai, India


Introduction/Background There is paucity of long term collected data from India of comprehensively staged high grade endometrial cancer. This is a retrospective study of high-grade endometrial cancer over a period of 10 years at a tertiary care hospital in gynaecologic oncology department.

Methodology 84 patients underwent surgical staging including pelvic lymphadenectomy with or without para-aortic lymphadenectomy. Adjuvant chemotherapy, pelvic radiotherapy and brachytherapy were given to patients based on risk factors.

Results The median age was 64 years. 42(50.59%) patients were early stage, and 42(49.41%) patients were advanced stage. Of the advanced stage, 17 (20.2%) patients received neoadjuvant chemotherapy. 49(58.33%) patients had non endometroid histology. The median follow up was 73 months 27 patients. (32.1%) had lymph node positivity. 13 out of 27 patients (48.1 %) with pelvic node metastasis also had para-aortic involvement. 3 patients (11 %) had isolated para-aortic lymph node metastasis. 19 (22.6%) recurrences were reported with majority being distant recurrences. 3- and 5-year DFS was 76.66% and 66.67 % and 3- and 5-year OS was 90 % and 76.47 % respectively. Lymph-vascular invasion was significant predictor of recurrence. Multivariate analysis of prognostic parameters impacting survival was done.

Conclusion With appropriate staging and risk-based adjuvant treatment, there is potential to achieve good survival outcomes in high grade endometrial cancers.

Disclosures No disclosures.

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.